Literature DB >> 15183347

Impact of the translocational equilibrium of HIV-1 reverse transcriptase on the efficiency of mismatch extensions and the excision of mispaired nucleotides.

Bruno Marchand1, Matthias Götte.   

Abstract

The reverse transcriptase of the human immunodeficiency virus type 1 (HIV-1 RT) does not possess an exonucleolytic proofreading activity; however, previous studies have shown that this enzyme can excise incorporated chain-terminators in the presence of pyrophosphate or ATP. This type of reaction provides a plausible mechanism for HIV-1 resistance to several nucleoside analogue inhibitors. Here we studied the efficiency of pyrophosphorolysis in the context of mismatched nucleotides, and found that the removal of dCMP and dTMP opposite T is literally blocked. Thus, pyrophosphorolysis may not provide an alternative, universal proofreading mechanism, although excision of dGMP and the correct dAMP opposite T can occur with considerable efficiency. Site-specific footprinting experiments revealed that the 3' end of C:T- and T:T-mispaired primer strands is predominantly found in a post-translocational configuration, which prevents the removal of terminal nucleotides. In contrast, complexes containing G:T and A:T base pairs can exist in both post- and pre-translocational stages. Excision can only occur in the latter, which helps to explain the observed selectivity of the reaction. The efficiency of mismatch extensions does not appear to depend on pre-existing changes of the translocational equilibrium. However, footprints of complexes containing 3' penultimate mismatches suggest that the incorporation of the first nucleotide following the mispair can force the enzyme to slide backwards, which can inhibit ensuing polymerization events. The fact that misincorporated nucleotides can affect the precise positioning of RT provides a rational for the development of novel nucleoside analogue inhibitors that contain modifications in the base moiety. Copyright 2004 Elsevier B.V.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15183347     DOI: 10.1016/j.biocel.2004.02.029

Source DB:  PubMed          Journal:  Int J Biochem Cell Biol        ISSN: 1357-2725            Impact factor:   5.085


  12 in total

1.  K65R and K65A substitutions in HIV-1 reverse transcriptase enhance polymerase fidelity by decreasing both dNTP misinsertion and mispaired primer extension efficiencies.

Authors:  Scott J Garforth; Robert A Domaoal; Chisanga Lwatula; Mark J Landau; Amanda J Meyer; Karen S Anderson; Vinayaka R Prasad
Journal:  J Mol Biol       Date:  2010-06-09       Impact factor: 5.469

2.  Formation of a quaternary complex of HIV-1 reverse transcriptase with a nucleotide-competing inhibitor and its ATP enhancer.

Authors:  Maryam Ehteshami; Monique Nijhuis; Jean A Bernatchez; Christopher J Ablenas; Suzanne McCormick; Dorien de Jong; Dirk Jochmans; Matthias Götte
Journal:  J Biol Chem       Date:  2013-04-18       Impact factor: 5.157

3.  Nucleotide Sugar Pucker Preference Mitigates Excision by HIV-1 RT.

Authors:  Ken Yamada; Alexander S Wahba; Jean A Bernatchez; Tatiana Ilina; Saúl Martínez-Montero; Maryam Habibian; Glen F Deleavey; Matthias Götte; Michael A Parniak; Masad J Damha
Journal:  ACS Chem Biol       Date:  2015-07-22       Impact factor: 5.100

4.  Derivatives of mesoxalic acid block translocation of HIV-1 reverse transcriptase.

Authors:  Jean A Bernatchez; Rakesh Paul; Egor P Tchesnokov; Marianne Ngure; Greg L Beilhartz; Albert M Berghuis; Rico Lavoie; Lianhai Li; Anick Auger; Roman A Melnyk; Jay A Grobler; Michael D Miller; Daria J Hazuda; Sidney M Hecht; Matthias Götte
Journal:  J Biol Chem       Date:  2014-10-29       Impact factor: 5.157

5.  Delayed chain termination protects the anti-hepatitis B virus drug entecavir from excision by HIV-1 reverse transcriptase.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2008-10-20       Impact factor: 5.157

6.  Mechanisms associated with HIV-1 resistance to acyclovir by the V75I mutation in reverse transcriptase.

Authors:  Egor P Tchesnokov; Aleksandr Obikhod; Ivana Massud; Andrea Lisco; Christophe Vanpouille; Beda Brichacek; Jan Balzarini; Christopher McGuigan; Marco Derudas; Leonid Margolis; Raymond F Schinazi; Matthias Götte
Journal:  J Biol Chem       Date:  2009-06-09       Impact factor: 5.157

7.  Effects of the translocation status of human immunodeficiency virus type 1 reverse transcriptase on the efficiency of excision of tenofovir.

Authors:  Bruno Marchand; Kirsten L White; John K Ly; Nicolas A Margot; Ruth Wang; Martin McDermott; Michael D Miller; Matthias Götte
Journal:  Antimicrob Agents Chemother       Date:  2007-05-21       Impact factor: 5.191

Review 8.  The remarkable frequency of human immunodeficiency virus type 1 genetic recombination.

Authors:  Adewunmi Onafuwa-Nuga; Alice Telesnitsky
Journal:  Microbiol Mol Biol Rev       Date:  2009-09       Impact factor: 11.056

9.  Resolution of Specific Nucleotide Mismatches by Wild-Type and AZT-Resistant Reverse Transcriptases during HIV-1 Replication.

Authors:  Siarhei Kharytonchyk; Steven R King; Clement B Ndongmo; Krista L Stilger; Wenfeng An; Alice Telesnitsky
Journal:  J Mol Biol       Date:  2016-04-10       Impact factor: 5.469

10.  Pyrophosphorolytic excision of nonobligate chain terminators by hepatitis C virus NS5B polymerase.

Authors:  Jérôme Deval; Megan H Powdrill; Claudia M D'Abramo; Luciano Cellai; Matthias Götte
Journal:  Antimicrob Agents Chemother       Date:  2007-05-14       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.